23448 (LAB.TO) (LAB) Scheduled to Post Earnings on Thursday

23448 (LAB.TO) (TSE:LABGet Free Report) will be announcing its earnings results before the market opens on Thursday, November 14th.

23448 (LAB.TO) (TSE:LABGet Free Report) last released its earnings results on Wednesday, August 14th. The company reported C($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of C($0.01). The business had revenue of C$11.14 million for the quarter, compared to analysts’ expectations of C$10.26 million.

23448 (LAB.TO) Stock Performance

About 23448 (LAB.TO)

(Get Free Report)

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies.

Featured Stories

Earnings History for 23448 (LAB.TO) (TSE:LAB)

Receive News & Ratings for 23448 (LAB.TO) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23448 (LAB.TO) and related companies with MarketBeat.com's FREE daily email newsletter.